MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling

Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer

(2019) Jianan Chen et al.   Molecular Cancer

MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma

(2018) Jianan Chen et al.   CELL PROLIFERATION

MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway

(2018) Jie Bao et al.   Cell Death & Disease

Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2

(2017) Linli Tian et al.   Oncotarget

MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer

(2016) Ming-Ming Tsai et al.   Oncotarget

Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma

(2016) Yong Wang et al.   Oncotarget

MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X

(2014) Gang Shen et al.   BMC CANCER

MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3

(2014) Na Zhao et al.   Molecular Cancer

miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1

(2013) Y Shang et al.   ONCOGENE

MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11

(2011) Xiao-Xiao Liu et al.   FEBS LETTERS

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

(2010) A. P. Venook et al.   ONCOLOGIST

Expression and Prognostic Value of ZNRD1 in Esophageal Squamous Cell Carcinoma

(2008) Yunping Zhao et al.   DIGESTIVE DISEASES AND SCIENCES